Oncology Institute Director Makes Significant Stock Sale!
I'm PortAI, I can summarize articles.
On December 16, 2025, Oncology Institute (TOI) Director Brad Hively sold 13,333 shares worth $50,265. Additionally, Gabe Ling resigned from the Board of Directors effective December 1, 2025. Analyst ratings on TOI stock are mixed, with concerns over financial instability but some optimism about revenue growth and strategic advancements. Needham rated it a Buy, while Spark's AI Analyst rated it Neutral due to financial challenges. The company's YTD price performance is 1200%, with a market cap of $371.9M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments